Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gene therapy in cardiovascular diseases].

P Gregor1

  • 1III. interní-kardiologická klinika-Kardiocentrum 3. LF UK a FNKV, Praha. gregor@fnkv.cz

Casopis Lekaru Ceskych
|November 12, 2003
PubMed
Summary

Gene therapy (GT) shows promise for treating heart failure, preventing restenosis after PCI, and promoting therapeutic angiogenesis. Further randomized studies are needed to confirm its safety and efficacy in cardiovascular applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy.

Folia biologica·2014
Same author

[Not Available].

Vnitrni lekarstvi·2013
Same author

[Malignant heart neoplasms].

Vnitrni lekarstvi·2013
Same author

[Aortic stenosis].

Vnitrni lekarstvi·2013
Same author

[Cardiac myxoma--editorial].

Vnitrni lekarstvi·2013
Same author

[Aortic regurgitation].

Vnitrni lekarstvi·2013

Area of Science:

  • Cardiovascular Medicine
  • Molecular Cardiology
  • Gene Therapy

Context:

  • Gene therapy (GT) is emerging as a potential treatment for critical cardiovascular conditions.
  • Current research focuses on neoangiogenesis, heart failure, and preventing restenosis post-percutaneous coronary intervention (PCI).
  • Existing revascularization methods are insufficient for some patients with advanced myocardial ischemia or angina pectoris.

Purpose:

  • To explore the main targets and potential applications of gene therapy in cardiology.
  • To review the mechanisms and indications for gene therapy in treating heart failure.
  • To assess the feasibility of gene therapy for preventing restenosis after PCI and other cardiovascular conditions.

Summary:

  • Gene therapy targets include therapeutic angiogenesis for myocardial ischemia and angina, and heart failure treatment via modulation of calcium homeostasis, beta-adrenergic receptors, and myocyte apoptosis resistance.
  • Gene therapy also shows potential for preventing restenosis after PCI and in treating systemic and pulmonary hypertension.
  • Research is ongoing to define optimal vectors, delivery methods (transmyocardial and intravenous), and dosages, with initial findings suggesting GT is safe and well-tolerated.

Impact:

  • Gene therapy offers a novel therapeutic avenue for complex cardiovascular diseases unresponsive to conventional treatments.
  • Successful implementation could significantly improve outcomes for patients with heart failure, ischemic heart disease, and post-PCI complications.
  • Further clinical trials are essential to validate the efficacy and long-term safety of gene therapy in cardiology.

Related Experiment Videos